Ptc Therapeutics (PTCT) Non-Current Assets (2012 - 2026)

Ptc Therapeutics' Non-Current Assets history runs 15 years deep, the most recent figure standing at $633.1 million for Q2 2026.

• In Q2 2026, Non-Current Assets rose 75.24% year-over-year to $633.1 million; the TTM figure through Jun 2026 stood at $2.5 billion (up 56.77% YoY), while the FY2025 annual figure was $624.8 million, up 84.04% from the prior year.
• Non-Current Assets for Q2 2026 stood at $633.1 million, up from $615.1 million in the prior quarter.
• The five-year high for Non-Current Assets was $1.1 billion in Q2 2022, with the low at $339.0 million in Q1 2025.
• The 5-year median for Non-Current Assets is $634.5 million (2025), against an average of $702.0 million.
• The sharpest annual moves came in 2024 and 2025: Non-Current Assets tumbled 49.86% in 2024, then jumped 84.04% in 2025.
• Ptc Therapeutics' Non-Current Assets stood at $1.0 billion in 2022, then tumbled by 33.08% to $677.1 million in 2023, then sank by 49.86% to $339.5 million in 2024, then soared by 84.04% to $624.8 million in 2025, then grew by 1.33% to $633.1 million in 2026.
• Business Quant data shows PTCT's Non-Current Assets at $633.1 million in Q2 2026, $615.1 million in Q1 2026, and $624.8 million in Q4 2025.